Literature DB >> 8852439

Prognostic importance of hyperplasia and atypia in endometriosis.

J D Seidman1.   

Abstract

Endometriosis occasionally exhibits cytologic atypia in the lining of endometriotic cysts or hyperplasia resembling uterine endometrial hyperplasias, but the risk of development of adenocarcinoma in these patients is unknown. A total of 105 women with endometriosis were studied: 37 with cytologic atypia (usually in the lining of endometriotic cysts), 34 with hyperplasia resembling uterine endometrial hyperplasia, and 34 controls. For lesions resembling eutopic endometrial hyperplasia, the Kurman-Norris criteria for separating atypical hyperplasia from well-differentiated endometrial adenocarcinoma were used to subdivide this group into 23 complex atypical hyperplasias and 11 "early carcinomas." Some 62 women were successfully followed for a mean of 8.7 years. One patient with early carcinoma developed a poorly differentiated endometrioid adenocarcinoma at the vaginal apex 8.1 years later. A second patient with early carcinoma developed a mullerian mucinous tumor of low malignant potential in the contralateral ovary 7 years later. Both of the latter two patients had multifocal endometriosis. Except for persistent benign endometriotic lesions in four patients, and breast carcinoma in one, all remaining patients were alive and well at last contact. It is concluded that the Kurman-Norris criteria for eutopic endometrial adenocarcinoma may be useful in identifying rare patients with endometriosis in whom there may be an increased risk of neoplastic transformation of their endometriosis.

Entities:  

Mesh:

Year:  1996        PMID: 8852439     DOI: 10.1097/00004347-199601000-00001

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  18 in total

1.  Identification of common mechanisms between endometriosis and ovarian cancer.

Authors:  Qingsong Meng; Weixue Sun; John Jiang; Nicole M Fletcher; Michael P Diamond; Ghassan M Saed
Journal:  J Assist Reprod Genet       Date:  2011-05-26       Impact factor: 3.412

2.  Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer.

Authors:  Swati Suryawanshi; Xin Huang; Esther Elishaev; Raluca A Budiu; Lixin Zhang; SungHwan Kim; Nicole Donnellan; Gina Mantia-Smaldone; Tianzhou Ma; George Tseng; Ted Lee; Suketu Mansuria; Robert P Edwards; Anda M Vlad
Journal:  Clin Cancer Res       Date:  2014-10-07       Impact factor: 12.531

3.  Atypical epithelial changes and mutant p53 gene expression in ovarian endometriosis.

Authors:  H Bayramoğlu; E Düzcan
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

4.  Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk.

Authors:  Zhen Zhen Zhao; Pamela M Pollock; Shane Thomas; Susan A Treloar; Dale R Nyholt; Grant W Montgomery
Journal:  Hum Reprod       Date:  2008-02-18       Impact factor: 6.918

Review 5.  [Endometriosis-related ovarian tumors].

Authors:  D Schmidt; U Ulrich
Journal:  Pathologe       Date:  2014-07       Impact factor: 1.011

6.  An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway.

Authors:  Sohei Yamamoto; Hitoshi Tsuda; Kozue Suzuki; Masashi Takano; Seiichi Tamai; Osamu Matsubara
Journal:  Virchows Arch       Date:  2009-08-05       Impact factor: 4.064

7.  Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways.

Authors:  Sohei Yamamoto; Hitoshi Tsuda; Kosuke Miyai; Masashi Takano; Seiichi Tamai; Osamu Matsubara
Journal:  Virchows Arch       Date:  2009-10-24       Impact factor: 4.064

Review 8.  Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.

Authors:  Masaki Mandai; Ken Yamaguchi; Noriomi Matsumura; Tsukasa Baba; Ikuo Konishi
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

Review 9.  Endometriosis-associated Malignancy.

Authors:  N Krawczyk; M Banys-Paluchowski; D Schmidt; U Ulrich; T Fehm
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-02       Impact factor: 2.915

10.  Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.

Authors:  Swati Suryawanshi; Anda M Vlad; Hui-Min Lin; Gina Mantia-Smaldone; Robin Laskey; Minjae Lee; Yan Lin; Nicole Donnellan; Marcia Klein-Patel; Ted Lee; Suketu Mansuria; Esther Elishaev; Raluca Budiu; Robert P Edwards; Xin Huang
Journal:  Clin Cancer Res       Date:  2013-01-29       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.